Cathy Gwin
Senior Director, Communications
News
Media Contact
NTI | bio VP Urges Action Against Emerging Risks to Prevent Biotechnology Catastrophe
In a new article for the CTC Sentinel, NTI | bio Vice President Jaime Yassif explains how advances in bioscience and biotechnology are accompanied by emerging biological risks and cites the need for action to safeguard the life sciences to prevent biotechnology catastrophe.
NTI and WEF Convene Third Annual Meeting of DNA Synthesis Screening Technical Consortium
NTI | bio and the World Economic Forum (WEF) convened the third annual meeting of the Technical Consortium on DNA Synthesis Screening on May 12-13, 2022.
NTI | bio Experts Propose New International Organization to Address Increasing Biotechnology Risks
In a new perspective penned for Science and Diplomacy, NTI | bio’s Margaret Hamburg, Jaime Yassif, Hayley Severance and former NTI David A. Hamburg Distinguished Fellow R. Alta Charo highlight the increasing risks of accidental or deliberate misuse of modern bioscience and biotechnology, and propose the establishment of a new organization.
NTI and WEF Convene Second Annual Meeting of DNA Synthesis Screening Technical Consortium
DNA synthesis is a key service that supports the growing bioeconomy, and demand for customized synthetic DNA is growing
NTI Launches New Global Biosecurity Innovation and Risk Reduction Initiative
NTI bio launches the Biosecurity Innovation and Risk Reduction Initiative to reduce global catastrophic biological risks associated with biotechnology.
B-roll North Korean Nuclear Test
B-Roll IRAN Natanz Enrichment Complex
B-roll Rattehalli Materials Plant - India
Stay Informed
Sign up for our newsletter to get the latest on nuclear and biological threats.
